Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 6/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12565004 | 0.78 | TERT (0.50) | TERTATMPARP1TLR8KCNH2 | |
| SCHEMBL10496032 | 0.70 | KMT2A (0.44) | TERTATMPARP1KCNH2SCN5A | |
| SCHEMBL28827733 | 0.70 | KMT2A (0.53) | TERTATMPARP1GABRA1GABRB2 | |
| SCHEMBL7051195 | 0.68 | MCHR1 (0.54) | — | |
| SCHEMBL25520946 | 0.68 | GABRA1 (0.44) | TERTATMPARP1GABRA1GABRB2 | |
| SCHEMBL15119498 | 0.68 | MEN1 (0.53) | TERTPARP1GABRA1GABRB2MEN1 | |
| SCHEMBL27416308 | 0.68 | PARP1 (0.61) | TERTPARP1 | |
| SCHEMBL1889250 | 0.66 | MEN1 (0.43) | ATMMEN1KMT2AMAPTPIK3CD | |
| SCHEMBL19552354 | 0.66 | ALDH1A1 (0.42) | GABRA1GABRB2MAPT | |
| SCHEMBL9909149 | 0.66 | METAP2 (0.55) | PARP1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103946-B1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2024-03-13 | — | — | EP | claimed |
| US-20230109016-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2023-04-06 | — | — | US | claimed |
| EP-4103946-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | Immundiagnostik AG (DE) | 2022-12-21 | — | — | EP | claimed |
| WO-2021160696-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2021-08-19 | — | — | WO | claimed |
| EP-4103946-B1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| US-20230109016-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2023-04-06 | — | — | US | disclosed |
| EP-4103946-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | Immundiagnostik AG (DE) | 2022-12-21 | — | — | EP | disclosed |
| WO-2021160696-A1 | IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2021-08-19 | — | — | WO | disclosed |